Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset
拉泽替尼与吉非替尼作为EGFR突变局部晚期或转移性非小细胞肺癌一线治疗的比较:LASER301韩国亚组
期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2023.453
Lee, Ki Hyeong; Cho, Byoung Chul; Ahn, Myung-Ju; Lee, Yun-Gyoo; Lee, Youngjoo; Lee, Jong-Seok; Kim, Joo-Hang; Min, Young Joo; Lee, Gyeong-Won; Lee, Sung Sook; Lee, Kyung-Hee; Ko, Yoon Ho; Shim, Byoung Yong; Kim, Sang-We; Shin, Sang Won; Choi, Jin-Hyuk; Kim, Dong-Wan; Cho, Eun Kyung; Park, Keon Uk; Kim, Jin-Soo; Chun, Sang Hoon; Wang, Jangyoung; Choi, SeokYoung; Kang, Jin Hyoung